|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-8-1
|
|
pubmed:abstractText |
To investigate the effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand on angiotensin II (AngII)-induced endothelin-1 (ET-1) and NO secretion by endothelial cells in comparison with AngII type I receptor (AT1R) antagonist losartan, so as to reveal the relationship between PPAR gamma and essential hypertension.
|
|
pubmed:language |
chi
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II Type 1 Receptor...,
http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Chromans,
http://linkedlifedata.com/resource/pubmed/chemical/Endothelin-1,
http://linkedlifedata.com/resource/pubmed/chemical/Losartan,
http://linkedlifedata.com/resource/pubmed/chemical/Nitric Oxide,
http://linkedlifedata.com/resource/pubmed/chemical/PPAR gamma,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Angiotensin, Type 1,
http://linkedlifedata.com/resource/pubmed/chemical/Thiazolidinediones,
http://linkedlifedata.com/resource/pubmed/chemical/troglitazone
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1673-4254
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1030-3
|
|
pubmed:meshHeading |
pubmed-meshheading:17666345-Angiotensin II,
pubmed-meshheading:17666345-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:17666345-Animals,
pubmed-meshheading:17666345-Antihypertensive Agents,
pubmed-meshheading:17666345-Cell Line,
pubmed-meshheading:17666345-Chromans,
pubmed-meshheading:17666345-Dose-Response Relationship, Drug,
pubmed-meshheading:17666345-Endothelial Cells,
pubmed-meshheading:17666345-Endothelin-1,
pubmed-meshheading:17666345-Gene Expression Regulation,
pubmed-meshheading:17666345-Humans,
pubmed-meshheading:17666345-Hypertension,
pubmed-meshheading:17666345-Immunohistochemistry,
pubmed-meshheading:17666345-Losartan,
pubmed-meshheading:17666345-Nitric Oxide,
pubmed-meshheading:17666345-PPAR gamma,
pubmed-meshheading:17666345-Receptor, Angiotensin, Type 1,
pubmed-meshheading:17666345-Thiazolidinediones
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
[Peroxisome proliferator-activated receptor activator troglitazone inhibits angiotensin II-stimulated secretion of vasoactive factors by endothelial cells].
|
|
pubmed:affiliation |
Department of Cardiology, Second Hospital of Xi'an Jiaotong University, and Department of Pathophysiology, Xi'an Jiaotong University, China.
|
|
pubmed:publicationType |
Journal Article,
English Abstract
|
